Buccal Drug Delivery Systems Market Size, Share, Trends, Growth Outlook

Buccal Drug Delivery Systems Market is estimated to increase at a growth rate of 9.5% CAGR over the forecast period from 2024 to 2030.

The Buccal Drug Delivery Systems Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Type (Sublingual Films, Buccal Tablets and Lozenges, Oral Sprays), By Application (Pain Management, Smoking Cessation, Angina Pectoris, Others), By End-User (Hospitals, Ambulatory Centers, Others).

An Introduction to Buccal Drug Delivery Systems Market in 2024

The Buccal Drug Delivery Systems market in 2024 showcases innovative approaches to drug administration, leveraging the buccal mucosa as a site for drug absorption and systemic delivery. Buccal drug delivery systems, including mucoadhesive patches, films, and tablets, offer advantages such as rapid onset of action, avoidance of first-pass metabolism, and patient convenience. Market growth is driven by factors such as the demand for non-invasive drug delivery routes, advancements in formulation technology, and the development of novel therapeutics requiring precise dosing and pharmacokinetic profiles. Collaboration between pharmaceutical companies, formulation scientists, and regulatory agencies fosters innovation and market penetration of buccal drug delivery systems, addressing unmet needs in patient care and drug therapy optimization.

Buccal Drug Delivery Systems Market Trend: Growing Preference for Non-Invasive Drug Delivery

A prominent trend in the Buccal Drug Delivery Systems market is the growing preference for non-invasive drug delivery routes, driven by patient convenience, improved bioavailability, and reduced systemic side effects. Buccal drug delivery offers a non-invasive alternative to traditional routes such as oral administration, bypassing first-pass metabolism and gastrointestinal degradation. This trend is particularly evident in the pharmaceutical industry's efforts to develop novel buccal formulations for various therapeutic indications, including pain management, hormone replacement therapy, and neurological disorders, contributing to market expansion for buccal drug delivery systems.

Buccal Drug Delivery Systems Market Driver: Increasing Demand for Targeted and Controlled Drug Delivery

The primary driver for the Buccal Drug Delivery Systems market is the increasing demand for targeted and controlled drug delivery solutions. Buccal drug delivery systems allow for precise dosing and targeted release of medications directly into the bloodstream via the highly vascularized oral mucosa, offering controlled drug release kinetics and therapeutic concentrations at the site of action. This targeted approach minimizes systemic exposure, reduces the risk of adverse effects, and enhances drug efficacy, driving their adoption across various therapeutic areas. The demand for buccal drug delivery systems is further fueled by advancements in formulation technologies, enabling the development of sustained-release and mucoadhesive dosage forms that prolong drug residence time in the buccal cavity, thereby optimizing therapeutic outcomes.

Buccal Drug Delivery Systems Market Opportunity: Expansion into Novel Therapeutic Areas

An opportunity in the Buccal Drug Delivery Systems market lies in the expansion into novel therapeutic areas with unmet medical needs. While buccal drug delivery systems have been primarily utilized for certain classes of medications such as opioids, hormones, and antiemetics, there is a growing opportunity to explore their application in emerging therapeutic areas such as immunotherapy, gene therapy, and biologics delivery. Innovations in formulation techniques, nanotechnology, and mucoadhesive polymers enable the development of specialized buccal formulations capable of delivering complex therapeutic agents with enhanced stability and bioavailability. By leveraging these advancements, pharmaceutical companies can capitalize on the expanding landscape of targeted therapies and personalized medicine, positioning buccal drug delivery systems as versatile platforms for the treatment of a wide range of diseases and conditions, thereby unlocking new growth opportunities in the market.

Buccal Drug Delivery Systems Market Segmentation

By Type
Sublingual Films
Buccal Tablets and Lozenges
Oral Sprays
By Application
Pain Management
Smoking Cessation
Angina Pectoris
Others
By End-user
Hospitals
Ambulatory Centers
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

 

Buccal Drug Delivery Systems Market Companies

ARx LLC
BioDelivery Sciences International Inc
Catalent
Cynapsus Therapeutics Inc
Endo Pharmaceuticals plc
Generex Biotechnology
GlaxoSmithKline plc
Indivior Pharmaceuticals
Pfizer Inc
Teva Pharmaceutical Industries Ltd

 

 

Reasons to Buy the Buccal Drug Delivery Systems Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Buccal Drug Delivery Systems Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Buccal Drug Delivery Systems Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

 

TABLE OF CONTENTS

1 Introduction to 2024 Buccal Drug Delivery Systems Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Buccal Drug Delivery Systems Market Size Outlook, $ Million, 2021 to 2030
3.2 Buccal Drug Delivery Systems Market Outlook by Type, $ Million, 2021 to 2030
3.3 Buccal Drug Delivery Systems Market Outlook by Product, $ Million, 2021 to 2030
3.4 Buccal Drug Delivery Systems Market Outlook by Application, $ Million, 2021 to 2030
3.5 Buccal Drug Delivery Systems Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Buccal Drug Delivery Systems Market Industry
4.2 Key Market Trends in Buccal Drug Delivery Systems Market Industry
4.3 Potential Opportunities in Buccal Drug Delivery Systems Market Industry
4.4 Key Challenges in Buccal Drug Delivery Systems Market Industry

5 Market Factor Analysis
5.1 Competitive Landscape
5.1.1 Global Buccal Drug Delivery Systems Market Share by Company (%), 2023
5.1.2 Product Offerings by Company
5.2 Porter’s Five Forces Analysis

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Buccal Drug Delivery Systems Market Outlook By Segments
7.1 Buccal Drug Delivery Systems Market Outlook by Segments
By Type
Sublingual Films
Buccal Tablets and Lozenges
Oral Sprays
By Application
Pain Management
Smoking Cessation
Angina Pectoris
Others
By End-user
Hospitals
Ambulatory Centers
Others

8 North America Buccal Drug Delivery Systems Market Analysis And Outlook To 2030
8.1 Introduction to North America Buccal Drug Delivery Systems Markets in 2024
8.2 North America Buccal Drug Delivery Systems Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Buccal Drug Delivery Systems Market size Outlook by Segments, 2021-2030
By Type
Sublingual Films
Buccal Tablets and Lozenges
Oral Sprays
By Application
Pain Management
Smoking Cessation
Angina Pectoris
Others
By End-user
Hospitals
Ambulatory Centers
Others

9 Europe Buccal Drug Delivery Systems Market Analysis And Outlook To 2030
9.1 Introduction to Europe Buccal Drug Delivery Systems Markets in 2024
9.2 Europe Buccal Drug Delivery Systems Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Buccal Drug Delivery Systems Market Size Outlook By Segments, 2021-2030
By Type
Sublingual Films
Buccal Tablets and Lozenges
Oral Sprays
By Application
Pain Management
Smoking Cessation
Angina Pectoris
Others
By End-user
Hospitals
Ambulatory Centers
Others

10 Asia Pacific Buccal Drug Delivery Systems Market Analysis And Outlook To 2030
10.1 Introduction to Asia Pacific Buccal Drug Delivery Systems Markets in 2024
10.2 Asia Pacific Buccal Drug Delivery Systems Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Buccal Drug Delivery Systems Market size Outlook by Segments, 2021-2030
By Type
Sublingual Films
Buccal Tablets and Lozenges
Oral Sprays
By Application
Pain Management
Smoking Cessation
Angina Pectoris
Others
By End-user
Hospitals
Ambulatory Centers
Others

11 South America Buccal Drug Delivery Systems Market Analysis And Outlook To 2030
11.1 Introduction to South America Buccal Drug Delivery Systems Markets in 2024
11.2 South America Buccal Drug Delivery Systems Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Buccal Drug Delivery Systems Market size Outlook by Segments, 2021-2030
By Type
Sublingual Films
Buccal Tablets and Lozenges
Oral Sprays
By Application
Pain Management
Smoking Cessation
Angina Pectoris
Others
By End-user
Hospitals
Ambulatory Centers
Others

12 Middle East And Africa Buccal Drug Delivery Systems Market Analysis And Outlook To 2030
12.1 Introduction to Middle East and Africa Buccal Drug Delivery Systems Markets in 2024
12.2 Middle East and Africa Buccal Drug Delivery Systems Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Buccal Drug Delivery Systems Market size Outlook by Segments, 2021-2030
By Type
Sublingual Films
Buccal Tablets and Lozenges
Oral Sprays
By Application
Pain Management
Smoking Cessation
Angina Pectoris
Others
By End-user
Hospitals
Ambulatory Centers
Others

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
ARx LLC
BioDelivery Sciences International Inc
Catalent
Cynapsus Therapeutics Inc
Endo Pharmaceuticals plc
Generex Biotechnology
GlaxoSmithKline plc
Indivior Pharmaceuticals
Pfizer Inc
Teva Pharmaceutical Industries Ltd

14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Type
Sublingual Films
Buccal Tablets and Lozenges
Oral Sprays
By Application
Pain Management
Smoking Cessation
Angina Pectoris
Others
By End-user
Hospitals
Ambulatory Centers
Others